Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Novel Genetic Disorders of the Immune System

View source ↗

Summary

NIAID is conducting a clinical trial investigating novel genetic immune disorders, including PI3KCD, CTLA4, STAT3GOF, and MAGT1 deficiencies, which is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: PI3KCD, CTLA4 | Status: RECRUITING